In Brief: Lornamead Settles On Lice Claims; DASCA Introduced In House; FDA Warns Supplement Firms
This article was originally published in The Tan Sheet
Executive Summary
Lornamead settles false claims allegations; DASCA bill introduced in House; FDA warns three firms about unapproved drug claims; Actavis expands manufacturing; Valeant defends reputation, Allergan bid; Tom’s Of Maine launches Toddler Training Toothpaste; and FDA to host Nutrition and Supplement Facts labels.